AYUSH- 64: A potential therapeutic agent in COVID-19

Corona Virus disease (COVID-19) has become a global pandemic resulting in large scale morbidity and mortality worldwide. The management of COVID-19 has been a big challenge because of multifactorial pathophysiology and no specific treatment. AYUSH-64, a poly-herbal formulation developed by CCRAS, Mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Ashok Kumar, Kar, Sarbeswar, Rai, Amit Kumar, Rao, B.C.S., Srikanth, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723836/
https://www.ncbi.nlm.nih.gov/pubmed/35002178
http://dx.doi.org/10.1016/j.jaim.2021.100538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723836/
https://www.ncbi.nlm.nih.gov/pubmed/35002178
http://dx.doi.org/10.1016/j.jaim.2021.100538

Ejemplares similares